Yahoo Web Search

Search results

1. www.atalantatx.comAtalanta Therapeutics » Home

   www.atalantatx.com

   • Cached

   Pioneering treatments for CNS diseases. Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders’ groundbreaking discoveries in RNA interference offer a powerful therapeutic approach to halt diseases at their source. Atalanta's branched siRNA.

   • Who We Are

     Atalanta is pioneering. new treatment options. for...

   • our science & focus

     Our science & focus. Our proprietary branched siRNA...

   • patients & families

     Atalanta’s initial therapeutic focus area is Huntington’s...

   • news

     October 14, 2019. Nature Biotechnology “Two new startups,...

   • join us

     Atalanta Therapeutics does not accept unsolicited resumes...

   • contact

     Contact Atalanta Therapeutics. 51 Sleeper Street, 7th Floor...

2. www.linkedin.com › company › atalanta-therapeuticsAtalanta Therapeutics | LinkedIn

   www.linkedin.com › company › atalanta-therapeutics

   Atalanta Therapeutics is a biotech company developing RNAi treatments for neurodegenerative diseases. Learn about their founders, employees, updates, events, and values on LinkedIn.

3. www.nature.com › articles › s41587/021/00838-2Atalanta pioneers siRNA for neurodegenerative diseases - Nature

   www.nature.com › articles › s41587/021/00838-2

   Feb 9, 2021 · Atalanta Therapeutics launched in January, announcing partnerships with Biogen and Genentech and $110 million in series A financing. The company was born from work described in a 2019 Nature...

4. www.genengnews.com › topics › omicsAtalanta Therapeutics Develops RNAi for Neurodegenerative ...

   www.genengnews.com › topics › omics

   • Cached

   Aug 26, 2022 · Headquartered in Boston, Atalanta Therapeutics is developing new treatment options for neurodegenerative diseases and other central nervous system (CNS) disorders by utilizing its proprietary...

5. www.umassmed.edu › news › news-archivesAtalanta Therapeutics founded by UMass Medical School and ...

   www.umassmed.edu › news › news-archives

   • Cached

   Jan 12, 2021 · Atalanta Therapeutics is a biotech founded by UMass Medical School and three faculty members to develop RNA therapeutics for Huntington's, Parkinson's and Alzheimer's diseases. It has launched with $110 million and collaborations with Biogen and Genentech.